儿童呼吸窘迫:加州院前急救方案与循证建议
该研究旨在制定儿童呼吸窘迫院前评估与治疗的循证建议,并比较加州33个地方EMS机构使用的儿童呼吸窘迫方案。作者通过广泛文献综述形成循证建议,聚焦三种表现:哮吼(喘鸣)、<24月龄喘息(毛细支气管炎)和>24月龄喘息(哮喘)。结果显示各机构方案差异很大:哮吼方案变异性最高,无任何治疗在所有机构中统一使用;仅3个(9.1%)机构区分<24月龄喘息并提及可能为毛细支气管炎;所有机构均纳入沙丁胺醇和肾上腺素(静脉/肌内)用于喘息(哮喘)方案;最少见的治疗为雾化肾上腺素(3/33)和镁剂(2/33);无机构将类固醇纳入方案(0/33)。作者提出的院前循证建议可能有助于EMS医疗主任制定和修订方案。
要点
- 加州33个地方EMS机构的儿童呼吸窘迫方案差异很大,哮吼方案变异性最高,无任何治疗在所有机构中统一使用。
- 仅3个(9.1%)地方EMS机构区分<24月龄儿童的喘息并提及可能为毛细支气管炎。
- 所有地方EMS机构均将沙丁胺醇和肾上腺素(静脉/肌内)纳入儿童喘息(哮喘)治疗方案。
- 喘息(哮喘)方案中最少见的治疗为雾化肾上腺素(3/33)和镁剂(2/33),无机构将类固醇纳入方案(0/33)。
- 作者提出的院前循证建议可能有助于EMS医疗主任制定和修订儿童呼吸窘迫方案。
适用人群与场景
- 院前环境中儿童呼吸窘迫患者,按表现分为哮吼(喘鸣)、<24月龄喘息(毛细支气管炎)和>24月龄喘息(哮喘)。
研究设计与关键结果
- 研究为文献综述形成循证建议,并比较加州33个地方EMS机构的儿童呼吸窘迫方案。
- 哮吼方案变异性最高,无任何治疗在所有机构中统一使用。
- 仅3个(9.1%)地方EMS机构区分<24月龄喘息并提及可能为毛细支气管炎。
- 所有地方EMS机构均将沙丁胺醇和肾上腺素(静脉/肌内)纳入儿童喘息(哮喘)治疗方案。
- 喘息(哮喘)方案中最少见的治疗为雾化肾上腺素(3/33)和镁剂(2/33),无机构将类固醇纳入方案(0/33)。
证据类型、等级与局限
- 证据类型:指南(循证建议),基于广泛文献综述形成。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,其提出的院前循证建议可能有助于EMS医疗主任制定和修订儿童呼吸窘迫方案。
指南或共识出处
- 原文为J Am Coll Emerg Physicians Open发表的指南(循证建议),标题为《儿童呼吸窘迫:加州院前急救方案与循证建议》。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Prehospital protocols vary across local emergency medical service (EMS) agencies in California. We sought to develop evidence-based recommendations for the out-of-hospital evaluation and treatment of pediatric respiratory distress, and we evaluated the protocols for pediatric respiratory distress used by the 33 California local EMS agencies.
METHODS: Evidence-based recommendations were developed through an extensive literature review of the current evidence regarding out-of-hospital treatment of pediatric patients with respiratory distress. The authors compared the pediatric respiratory distress protocols of each of the 33 California local EMS agencies with the evidence-based recommendations. Our focus was on the treatment of 3 main pediatric respiratory complaints by presentation: stridor (croup), wheezing < 24 months (bronchiolitis), and wheezing > 24 months (asthma).
RESULTS: Protocols across the 33 California local EMS agencies varied widely. Stridor (croup) had the highest protocol variability of the 3 presentations we evaluated, with no treatment having uniform use among all agencies. Only 3 (9.1%) of the local EMS agencies differentiated wheezing in children < 24 months of age, referencing this as possible bronchiolitis. All local EMS agencies included albuterol and epinephrine (intravenous/intramuscular) in their pediatric wheezing (asthma) treatment protocols. The least common treatments for wheezing (asthma) included nebulized epinephrine (3/33) and magnesium (2/33). No agencies included steroids in their treatment protocols (0/33).
CONCLUSION: Protocols for pediatric respiratory distress vary widely across the state of California, especially among those for stridor (croup) and wheezing in < 24 months (bronchiolitis). The evidence-based recommendations that we present for the prehospital treatment of these conditions may be useful for EMS medical directors tasked with creating and revising these protocols.
参考来源
- Cheng T, Farah J, Aldridge N, et al. Pediatric respiratory distress: California out-of-hospital protocols and evidence-based recommendations. J Am Coll Emerg Physicians Open. 2020. PMID: 33145546. doi:10.1002/emp2.12103
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。